Your browser is no longer supported. Please, upgrade your browser.
HSTO [NASD]
Histogen Inc.
Index- P/E- EPS (ttm)-0.58 Insider Own7.03% Shs Outstand41.73M Perf Week-9.50%
Market Cap12.47M Forward P/E- EPS next Y-0.32 Insider Trans0.00% Shs Float37.23M Perf Month-34.60%
Income-15.30M PEG- EPS next Q-0.10 Inst Own5.70% Short Float1.36% Perf Quarter-65.71%
Sales1.50M P/S8.31 EPS this Y-133.80% Inst Trans- Short Ratio0.72 Perf Half Y-70.19%
Book/sh0.51 P/B0.47 EPS next Y26.20% ROA-60.00% Target Price2.70 Perf Year-81.54%
Cash/sh0.37 P/C0.65 EPS next 5Y38.00% ROE-80.00% 52W Range0.25 - 1.98 Perf YTD-27.86%
Dividend- P/FCF- EPS past 5Y30.60% ROI-224.50% 52W High-87.88% Beta0.84
Dividend %- Quick Ratio8.50 Sales past 5Y- Gross Margin65.70% 52W Low-4.76% ATR0.03
Employees19 Current Ratio8.50 Sales Q/Q20.00% Oper. Margin- RSI (14)20.72 Volatility11.02% 8.87%
OptionableNo Debt/Eq0.00 EPS Q/Q65.50% Profit Margin- Rel Volume1.80 Prev Close0.26
ShortableYes LT Debt/Eq0.00 EarningsNov 10 AMC Payout- Avg Volume699.40K Price0.24
Recom1.50 SMA20-21.66% SMA50-41.74% SMA200-68.83% Volume1,259,944 Change-6.87%
Dec-21-21 06:19PM  
Dec-16-21 08:00AM  
Nov-26-21 05:11AM  
Nov-10-21 04:05PM  
Nov-08-21 04:05PM  
Nov-02-21 08:00AM  
Oct-27-21 08:00AM  
Aug-31-21 04:05PM  
Aug-16-21 08:00AM  
Aug-11-21 04:05PM  
Jul-29-21 04:05PM  
Jul-28-21 04:05PM  
Jun-30-21 08:00AM  
Jun-22-21 08:00AM  
Jun-09-21 04:01PM  
Jun-07-21 04:05PM  
Jun-03-21 08:00AM  
May-19-21 08:00AM  
May-13-21 04:01PM  
Apr-28-21 04:05PM  
Mar-30-21 08:00AM  
Mar-25-21 04:05PM  
Mar-16-21 08:00AM  
Mar-15-21 08:00AM  
Mar-11-21 04:01PM  
Mar-10-21 04:05PM  
Mar-04-21 04:05PM  
Mar-02-21 08:00AM  
Feb-16-21 08:00AM  
Jan-19-21 04:05PM  
Jan-07-21 09:46AM  
Jan-06-21 08:00AM  
Jan-05-21 04:05PM  
Dec-30-20 10:25PM  
Dec-17-20 08:00AM  
Dec-01-20 08:00AM  
Nov-16-20 04:05PM  
Nov-12-20 08:00AM  
Nov-10-20 04:05PM  
Oct-28-20 04:30PM  
Oct-27-20 08:00AM  
Oct-19-20 08:00AM  
Oct-05-20 08:00AM  
Sep-29-20 08:00AM  
Sep-16-20 08:00AM  
Sep-10-20 08:00AM  
Sep-01-20 04:15PM  
Aug-13-20 04:05PM  
Jul-30-20 04:15PM  
Jul-29-20 04:15PM  
Jul-20-20 04:10PM  
Jul-14-20 05:00AM  
Jun-03-20 08:00AM  
Histogen Inc., a clinical-stage therapeutics company, focuses on developing therapeutics based upon the products of fibroblast cells grown under simulated embryonic conditions. It offers HST-001, a hair stimulating complex that is in Phase 1b/2a clinical trial for the treatment of androgenic alopecia (hair loss); HST-003, a human extracellular matrix, which is in Phase 1/2 clinical trial to treat articular cartilage defects in the knee; and Emricasan, an orally active pan-caspase inhibitor that is in Phase 1 clinical trial for the treatment of COVID-19. The company's pre-clinical programs include HST-004, a cell conditioned media (CCM) solution to treat spinal disc repair; and HST-002, a human-derived collagen and extracellular matrix dermal filler for the treatment of facial folds and wrinkles. Histogen Inc. was founded in 2007 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pascoe Richard WPresident, CEO & DirectorMar 30Buy1.1420,00022,80030,000Mar 30 06:28 PM